Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy

This commentary provides an independent consideration of data related to the drug vamorolone (VBP15) as an alternative steroid proposed for treatment of Duchenne muscular dystrophy (DMD). Glucocorticoids such as prednisone and deflazacort have powerful anti-inflammatory benefits and are the standard...

Descripción completa

Detalles Bibliográficos
Autores principales: Grounds, Miranda D., Lloyd, Erin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657680/
https://www.ncbi.nlm.nih.gov/pubmed/37927274
http://dx.doi.org/10.3233/JND-230161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657680/
https://www.ncbi.nlm.nih.gov/pubmed/37927274
http://dx.doi.org/10.3233/JND-230161

Ejemplares similares